BioAtla Presents Compelling Mechanistic Rationale for Targeting ROR2 with Ozuriftamab Vedotin in Oropharyngeal Squamous Cell Carcinoma at the Annual Conference of the International Papillomavirus Society Biotech Investing
Cidara Therapeutics Announces Late-Breaking Presentation on CD388 at 10?? ESWI Influenza Conference 2025 Biotech Investing
argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025 Biotech Investing
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025 Biotech Investing
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology Convergence Meeting Biotech Investing
BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio Biotech Investing
